Drugs / ST-01
last change Jan 2026 re-read 2 minutes ago

ST-01

Developed for
chronic pain syndrome
Investigated by
Sustained Therapeutics Inc.

Trials 1 · a red edge is where a trial was stopped

202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT05707208 Mar 2023 → Dec 2025 chronic pain syndrome Sustained Therapeutics Inc. Completed No outcome recorded

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as ST-01 ClinicalTrials.gov intervention name — accepted as the source's own label NCT05707208
Known as Lidocaine Polymer Solution “A Randomized, Controlled Phase II Study of Repeat Dose ST-01 (Lidocaine Polymer Solution) vs Lidocaine for Spermatic Cord Block in Men With Chronic Scrotal Content Pain” NCT05707208